218697 Casein Kinase II Inhibitor I - CAS 17374-26-4 - Calbiochem

218697
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitéeDisponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service
      Voir les Prix & la Disponibilité

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      Empirical FormulaCAS #
      C₆HBr₄N₃ 17374-26-4

      Prix & Disponibilité

      Référence DisponibilitéConditionnement Qté Prix Quantité
      218697-10MG
      Récupération des données relatives à la disponibilité...
      Disponibilité limitéeDisponibilité limitée
      En stock 
      Interrompu(e)
      Disponible en quantités limitées
      Disponibilité à confirmer
        Pour le restant : Nous vous tiendrons informé
          Pour le restant : Nous vous tiendrons informé
          Nous vous tiendrons informé
          Contacter le Service Clients
          Contact Customer Service

          Ampoule plast. 10 mg
          Prix en cours de récupération
          Le prix n'a pas pu être récupéré
          La quantité minimale doit être un multiple de
          À la validation de la commande Plus d'informations
          Vous avez sauvegardé ()
           
          Demander le prix
          Description
          OverviewA cell-permeable benzotriazolo compound that acts as a higly selective, reversible, and ATP/GTP-competitive inhibitor of casein kinase-2 (CK2) (IC50 = 900 nM and 1.6 µM, using rat liver and human recombinant CK2, respectively) and DYRK (IC50 < 1 µM for DYRK1a). Its specificity has been demonstrated using a panel of 33 kinases, including PKA, PKB, PKC, MKK1, Erk2, p38, JNK, Lck, Lyn, and Syk. Also shown to inhibit NS3-associated viral helicase activities in HCV (IC50 = 20 and 60 µM, using DNA and RNA substrate, respectively) and WNV (IC50 = 1.7 and 900 nM, using DNA and RNA substrate, respectively). A 10 mM (5 mg/1.15 ml) solution of Casein Kinase II Inhibitor I (Cat. No. 218708) in DMSO, is also available.
          Catalogue Number218697
          Brand Family Calbiochem®
          SynonymsTBB, TBBt, 4,5,6,7-Tetrabromobenzotriazole, 4,5,6,7-Tetrabromo-2-azabenzimidazole, CK2 Inhibitor
          References
          ReferencesBorowski, P., et al. 2003. Eur. J. Biochem. 270, 1645.
          Sarno, S., et al. 2003. Biochem. J. 374, 639.
          Zien, P., et al. 2003. Biochem. Biophys. Res. Commun. 306, 129.
          Ruzzene, M., et al. 2002. Biochem. J. 364, 41.
          Sarno, S., et al. 2001. FEBS Lett. 496, 44.
          Szyszka, R., et al. 1995. Biochem. Biophys. Res. Commun. 208, 418.
          Product Information
          CAS number17374-26-4
          ATP CompetitiveY
          FormWhite solid
          Hill FormulaC₆HBr₄N₃
          Chemical formulaC₆HBr₄N₃
          ReversibleY
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          ApplicationCasein Kinase II Inhibitor I, CAS 17374-26-4, is a cell-permeable, selective, reversible, and ATP/GTP-competitive inhibitor of casein kinase-2 (IC50 = 900 nM for rat liver CK2).
          Biological Information
          Primary TargetCK2 rat liver, human recombinant
          Primary Target IC<sub>50</sub>900 nM and 1.6 µM, using rat liver and human recombinant CK2, respectively; < 1 µM for DYRK1a
          Purity≥99% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Carcinogenic / Teratogenic
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Casein Kinase II Inhibitor I - CAS 17374-26-4 - Calbiochem FDS

          Titre

          Fiche de données de sécurité des matériaux (FDS) 

          Casein Kinase II Inhibitor I - CAS 17374-26-4 - Calbiochem Certificats d'analyse

          TitreNuméro de lot
          218697

          Références bibliographiques

          Aperçu de la référence bibliographique
          Borowski, P., et al. 2003. Eur. J. Biochem. 270, 1645.
          Sarno, S., et al. 2003. Biochem. J. 374, 639.
          Zien, P., et al. 2003. Biochem. Biophys. Res. Commun. 306, 129.
          Ruzzene, M., et al. 2002. Biochem. J. 364, 41.
          Sarno, S., et al. 2001. FEBS Lett. 496, 44.
          Szyszka, R., et al. 1995. Biochem. Biophys. Res. Commun. 208, 418.
          Fiche technique

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision07-January-2009 JSW
          SynonymsTBB, TBBt, 4,5,6,7-Tetrabromobenzotriazole, 4,5,6,7-Tetrabromo-2-azabenzimidazole, CK2 Inhibitor
          DescriptionA cell-permeable benzotriazolo compound that acts as a highly selective, ATP/GTP-competitive casein kinase II (CKII) inhibitor (IC50 = 900 nM and 1.6 µM for rat liver and human recombinant CKII, respectively) and DYRK (IC50 <1 µM for DYRK1a). Specificity for CKII has been reported following the screening of 33 kinases, including PKA, Akt, PKC, MKK1, ERK2, p38, JNK, Lck, Lyn, and Syk. Also reported to inhibit NS3-associated viral helicase activity in hepatitis C virus (HCV) (IC50 = 20 and 60 µM using DNA and RNA substrates, respectively) and West Nile virus (WNV) (IC50 = 1.7 µM and 900 nM using DNA and RNA substrates, respectively).
          FormWhite solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number17374-26-4
          Chemical formulaC₆HBr₄N₃
          Structure formulaStructure formula
          Purity≥99% by HPLC
          SolubilityDMSO (10 mg/ml)
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Carcinogenic / Teratogenic
          ReferencesBorowski, P., et al. 2003. Eur. J. Biochem. 270, 1645.
          Sarno, S., et al. 2003. Biochem. J. 374, 639.
          Zien, P., et al. 2003. Biochem. Biophys. Res. Commun. 306, 129.
          Ruzzene, M., et al. 2002. Biochem. J. 364, 41.
          Sarno, S., et al. 2001. FEBS Lett. 496, 44.
          Szyszka, R., et al. 1995. Biochem. Biophys. Res. Commun. 208, 418.